Trials / Completed
CompletedNCT01938937
The Effect of Acute Transcranial Bright Light on Anxiety Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Oulu · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if transcranially administered bright light has acute effect on anxiety symptoms.
Detailed description
Subjects (n=30) with anxiety symptoms will be recruited into the study. To be included into the study, subjects have to get at least seven points in BAI(Becks Anxiety Inventory). At the beginning of the study subject will be randomly assigned to 12 minutes of acute transcranial bright light or placebo exposure group. Anxiety symptoms will be measured using Spielberger State-Trait Anxiety Inventory (STAI, form Y1)self-rating questionnaire just before and 10 and 110 minutes after the experiment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial bright light device | |
| DEVICE | Transcranial sham device |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2013-09-10
- Last updated
- 2014-02-26
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01938937. Inclusion in this directory is not an endorsement.